$BDX

BD Board Declares Dividend

BD (Becton, Dickinson and Company) (NYSE: BDX) said its board declared a quarterly dividend of $1.05 per common share. The dividend is payable Sept. 30, 2026, to shareholders of record Sept. 9, 2026, implying an annualized rate of $4.20 per share.

Original reporting
Published Jul 28, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$BDX
Neutral
high confidence
Mentioned
$BDX
Relevance
4/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$BDXNeutralLow
01

Why it matters

This is a corporate actions update that can affect short-term positioning for dividend capture, but it does not include new operating or financial guidance.

02

Market read

Primarily relevant for dividend-focused strategies and for tracking BD’s capital return cadence.

03

What to watch

Traders may care more about the ex-dividend date and yield versus the absolute dividend amount; those details are not provided here.

Relevance 4/10Novelty 3/10Timing: Dividend payable Sept. 30, 2026, record date Sept. 9, 2026.

Background

BD announced a quarterly cash dividend and provided the per-share amount plus record and payable dates.

Company-level read

Ticker impact

$BDXNeutralHigh confidence
Context

BD declared a quarterly dividend of $1.05 per share, payable Sept. 30, 2026, with record date Sept. 9, 2026.

Expected impact

Likely small, short-lived reaction; more relevant for income-focused positioning than for directional trading.

Evidence & confidence

The article discloses a routine quarterly dividend amount and key dates, without guidance changes, earnings, or balance-sheet risk.

Market effects

Minimal read-through for medical technology peers; dividend policy changes are typically company-specific.

No clear regional spillover indicated.

No global macro or regulatory linkage described.

Counterpoint

Income investors may bid the stock around ex-dividend timing, but this PR alone is unlikely to drive broad price discovery.

Key entities

  • BD (Becton, Dickinson and Company)

    Declared a quarterly dividend of $1.05 per common share, payable Sept. 30, 2026, to holders of record Sept. 9, 2026.

Related articles

$REPLMed

This Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more

FDA updates cover inspection reorganization plans, proposed IND reforms for early-stage biologics research, and accelerated approval of Replimune’s Tudriqev (vusolimogene oderparepvec-wtpg) with Bristol Myers Squibb’s Opdivo for melanoma after PD-1 regimens. Other items include FDA workshops, Seegene EUA for an assay, and multiple drug/device recalls.

$BDXMed

Becton, Dickinson Boosts FY26 Adj. EPS Outlook - Update

Becton, Dickinson and Co. (BDX) reported third-quarter results and raised its FY2026 adjusted EPS outlook to $12.62 to $12.72 per share, from $12.52 to $12.72. The company kept its revenue growth view, expecting low single-digit plus growth and low single-digit constant-currency growth. Shares were about $172.00 premarket.

$BDXMedAI 8/10

BD Reports Third Quarter Fiscal 2026 Financial Results

BD (NYSE:BDX) reported fiscal 2026 third-quarter results ended June 30, 2026. Revenue rose to $5.0 billion, up 5.4% reported and 4.4% on an FX-neutral basis. GAAP and adjusted diluted EPS from continuing operations were $1.64 and $3.23. Year-to-date cash from continuing operations increased 33.3% to $2.1 billion, and free cash flow rose 44.6% to $1.7 billion. BD updated full-year guidance, expecting revenue growth toward the high end and raised the adjusted EPS midpoint.